000			01995 a2200505 4500
005			20250515043154.0
264		0	_c20061113
008			200611s 0 0 fre d
022			_a0755-4982
024	7		_a10.1016/s0755-4982(06)74851-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aRibot, Claude
245	0	0	_a[Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk]. _h[electronic resource]
260			_bPresse medicale (Paris, France : 1983) _cOct 2006
300			_a1557-63 p. _bdigital
500			_aPublication Type: Comparative Study; English Abstract; Journal Article; Review
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBody Mass Index
650	0	4	_aBone Density Conservation Agents _xadministration & dosage
650	0	4	_aBreast Neoplasms _xchemically induced
650	0	4	_aControlled Clinical Trials as Topic
650	0	4	_aCoronary Disease _xchemically induced
650	0	4	_aDiphosphonates _xadministration & dosage
650	0	4	_aEstradiol _xadministration & dosage
650	0	4	_aEstrogen Replacement Therapy _xadverse effects
650	0	4	_aFemale
650	0	4	_aFemoral Fractures _xprevention & control
650	0	4	_aFractures, Bone _xprevention & control
650	0	4	_aHumans
650	0	4	_aLongitudinal Studies
650	0	4	_aMiddle Aged
650	0	4	_aOsteoporosis, Postmenopausal _xcomplications
650	0	4	_aProgestins _xadministration & dosage
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSpinal Fractures _xprevention & control
650	0	4	_aStroke _xchemically induced
650	0	4	_aThromboembolism _xchemically induced
650	0	4	_aTime Factors
650	0	4	_aVenous Thrombosis _xchemically induced
700	1		_aTrémollières, Florence
773	0		_tPresse medicale (Paris, France : 1983) _gvol. 35 _gno. 10 Pt 2 _gp. 1557-63
856	4	0	_uhttps://doi.org/10.1016/s0755-4982(06)74851-5 _zAvailable from publisher's website
999			_c16605249 _d16605249